Hjem › Eggstokkreft › California › Mountain View
Kliniske studier for Eggstokkreft i Mountain View, CA
19 studier for Eggstokkreft søker deltakere på steder i og rundt Mountain View (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
RekruttererFase 2/3
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi unna
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruttererFase 2
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi unna
- VA Palo Alto Health Care System, Palo Alto · 5 mi unna
A Study of PHST001 in Advanced Solid Tumors
RekruttererFase 1
- Stanford University School of Medicine, Palo Alto · 5 mi unna
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekruttererObservasjonsstudie
- Stanford University, Palo Alto · 5 mi unna
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekruttererFase 3
- Stanford Women's Cancer Center, Palo Alto · 5 mi unna
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekruttererFase 1
- Stanford University Medical Center, Stanford · 5 mi unna
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- Stanford Cancer Institute, Stanford · 5 mi unna
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors
RekruttererFase 1
- Stanford University, Palo Alto · 5 mi unna
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
RekruttererFase 1
- Stanford, Palo Alto · 5 mi unna
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruttererFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi unna
- og 1 flere
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RekruttererFase 2
- 150, Palo Alto · 5 mi unna
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
RekruttererFase 3
- Palo Alto Medical Foundation, Palo Alto · 5 mi unna
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekruttererFase 1/2
- Stanford University, Stanford · 5 mi unna
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
RekruttererFase 1/2
- Stanford Women's Cancer Center, Palo Alto · 5 mi unna
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
RekruttererObservasjonsstudie
- Stanford University School of Medicine, Stanford · 5 mi unna
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
RekruttererFase 1/2
- Stanford Cancer Institute, Stanford · 5 mi unna
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
RekruttererFase 3
- Stanford Ambulatory Surgery Center Lane Operating Room, Palo Alto · 5 mi unna
- Stanford Women's Cancer Center, Palo Alto · 5 mi unna
- Stanford Hospital, Palo Alto · 5 mi unna
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
RekruttererFase 2
- Stanford Cancer Center, Palo Alto · 5 mi unna
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Stanford · 5 mi unna
Eggstokkreft-studier i andre byer
- Houston, TX89 studier
- New York City, NY69 studier
- Boston, MA61 studier
- Los Angeles, CA50 studier
- Nashville, TN49 studier
- Arlington, VA46 studier
- Philadelphia, PA44 studier
- Columbus, OH39 studier
- St. Louis, MO38 studier
- Chicago, IL36 studier
- San Antonio, TX31 studier
- Cleveland, OH30 studier
Andre studier i Mountain View
- Kreft (alle typer)40 studier
- Brystkreft26 studier
- Metastatisk kreft25 studier
- Ikke-småcellet lungekreft21 studier
- Akut myelogen leukemi19 studier
- Autismespekterforstyrrelse17 studier
- Lungekreft17 studier
- Prostatakreft15 studier
- Hjertesvikt15 studier
- Autisme13 studier
- Akut lymfoblastisk leukemi13 studier
- Kolorektal kreft13 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.